Journal List > Allergy Asthma Respir Dis > v.4(5) > 1059208

Woo, Kim, Kim, Koh, Lee, and Ahn: Clinical difference between single infection and coinfection with respiratory virus: The 2014 single-center study

Abstract

Purpose

We investigated the clinical difference between single infection and coinfection with respiratory virus in hospitalized children with acute respiratory tract infections.

Methods

We reviewed 727 patients who were admitted with the diagnosis of acute respiratory infection at the Department of Pediatrics, Bundang Jesaeng Hospital between January and December of 2014. Diagnoses were made using the multiplex reverse transcriptase polymerase chain reaction (RT-PCR) assay targeting 16 viruses in nasopharyngeal swabs. Subjects were classified as the single virus infection and coinfection groups.

Results

A total of 439 patients were enrolled; 359 (77.2%) under 24 months. Single virus was detected in 279 (63.6%). Coinfection with multiple virus was detected in 160 (36.4%): 126 (28.7%) with 2 viruses, 30 (6.8%), and 4 (0.9%) with 3 to 4 viruses. Viral coinfection was detected in 28 samples (17.5%), with respiratory syncytial virus (RSV) A and rhinovirus being the most dominating combination. There were no clinical differences between the single infection and coinfection groups, except sputum and the frequency of high RSV load. Sputum was significantly more frequent in the coinfection group (P=0.043), and the frequency of high RSV load was significantly higher in the single infection group (P=0.029). Disease severity (high fever, the duration of fever [≥5 days], and the length of hospital stay [≥5 days], O2 therapy) did not differ significantly between both groups. RSV was a frequent virus of single infection during winter. Coinfection was most common in winter.

Conclusion

There were no clinical differences between single infection and coinfection, except sputum and the frequency of high RSV load.

Figures and Tables

Fig. 1

Percentage of coinfection, by respiratory virus. RSV, respiratory syncytial virus; RV, rhinovirus; MPV, metapneumovirus; PIV, parainfluenza; AdV, adenovirus; BoV, bocavirus; CoV, coronavirus; EV, enterovirus; IFV, influenza virus.

aard-4-360-g001
Fig. 2

Monthly distribution of single and coinfection. RSV, respiratory syncytial virus; RV, rhinovirus; MPV, metapneumovirus; PIV, parainfluenza; AdV, adenovirus; BoV, bocavirus; CoV, coronavirus; EV, enterovirus; IFV, influenza virus.

aard-4-360-g002
Table 1

Demographic and clinical characteristics of the subjects (n=439)

aard-4-360-i001
Characteristic Value
Sex, male:female 267:172 (60.8:39.2)
Age (mo)
 Mean±SD 18.7±21.7
 Range 1–197
Clinical symptoms
 Fever 374 (85.2)
 Cough 420 (95.7)
 Sputum 366 (83.4)
 Rhinorrhea 231 (52.6)
 Dyspnea 31 (7.1)
Physical examination
 Inspection
  Tachypnea* 128 (29.1)
  Chest retraction 40 (9.1)
 Auscultation
  Normal 82 (18.7)
  Rhonchi 356 (81.1)
  Rale 130 (29.6)
  Wheezing 82 (18.7)
  Stridor 16 (3.6)
Laboratory findings
 WBC (cells/mm3) 11,345±4,303
  Neutrophil (%) 40.0±18.7
  Lymphocyte (%) 48.0±19.0
  Eosinophil (%) 1.4±2.3
  Monocyte (%) 11.0±6.8
 CRP (mg/dL) 1.6±2.7
Chest X-ray findings
 Normal 114 (260.0)
 Perihilar and peribronchial infiltration 272 (62.0)
 Consolidation 52 (11.8)
Diagnosis
 Pneumonia 242 (55.1)
 Bronchiolitis 126 (28.7)
 Bronchitis 34 (7.7)
 Croup 26 (5.9)
 Asthma exacerbation 4 (0.9)
 Nasopharyngitis 7 (1.6)
Severity
 Fever ≥ 39℃ 107 (24.4)
 Duration of fever ≥ 5 days 210 (47.8)
 Length of stay ≥ 5 days 207 (47.2)
 O2 therapy 27 (6.2)

Values are presented as number, mean±standard deviation (SD), or number of cases (%).

WBC, white blood cell; CRP, C-reactive protein.

*1–12 months, respiratory rate≥55/min; 13–36 months, respiratory rate≥30/min; 37–72 months, respiratory rate≥25/min; ≥73 months, respiratory rate≥22/min.

Table 2

Clinical characteristics of excluded subjects (n=128)

aard-4-360-i002
Excluded subjects Number Male:female Age (mo), mean ± SD Diagnosis
Neonate 23 12:11 0 Pneumonia (n = 14)
Bronchiolitis (n = 5)
Bronchitis (n = 4)
Underlying disease 3 1:2 20.3 ± 34.4 Cerebral palsy (n = 1)
Preterm baby (n = 1)
Wilms tumor (n = 1)
Antimycoplasmal IgM antibody (+) 101 45:56 42.1 ± 30.4 Pneumonia (n = 74)
Bronchiolitis (n = 9)
Bronchitis (n = 8)
Croup (n = 3)
Asthma exacerbation (n = 2)
Nasopharyngitis (n = 5)
Bacterial pneumonia 3 2:1 54.6 ± 28.4 Lung abscess (n = 3)
Blood culture (+) 1 1:0 31 Pneumonia (n = 1)

SD, standard deviation.

Table 3

Comparison of clinical characteristics between single and coinfection

aard-4-360-i003
Variable Single infection (n = 279) Coinfection (n = 160) P-value
Male:female 166:113 101:59 0.454
Age (mo) 18.8 ± 23.2 18.6 ± 18.8 0.956
 1–3 45 (16.1) 16 (10.0) 0.074
 4–12 91 (32.6) 47 (29.8) 0.481
 13–24 77 (27.6) 63 (39.4) 0.110
 25–60 57 (20.4) 29 (18.1) 0.558
 ≥ 61 9 (3.2) 5 (3.1) 0.954
Clinical symptoms
 Fever 223 (83.5) 141 (88.1) 0.190
 Cough 264 (94.6) 157 (98.1) 0.056
 Sputum 225 (80.6) 141 (88.1) 0.043
 Rhinorrhea 150 (53.8) 81 (50.6) 0.526
 Dyspnea 21 (7.5) 10 (6.3) 0.615
Physical examination
 Inspection
  Tachypnea* 84 (30.1) 44 (27.5) 0.372
  Chest retraction 30 (10.8) 10 (6.3) 0.119
 Auscultation
  Normal 120 (43.0) 61 (38.1) 0.317
  Rhonchi 159 (57.0) 99 (61.9) 0.317
  Rale 87 (31.2) 43 (26.9) 0.341
  Wheezing 48 (17.2) 34 (21.3) 0.295
  Stridor 8 (2.9) 8 (5.0) 0.251
Laboratory findings
 WBC (cells/mm3) 11,300±4,444 11,423±4,060 0.774
  Neutrophil (%) 39.9±49.1 40.4±18.1 0.778
  Lymphocyte (%) 48.8±20.3 46.5±16.7 0.228
  Eosinophil (%) 1.4±1.9 1.6±2.7 0.367
  Monocyte (%) 10.5±7.3 11.8±5.7 0.062
  CRP (mg/dL) 1.5±2.6 1.8±2.8 0.313
Chest X-ray
 Normal 77 (27.6) 38 (23.8) 0.377
 Perihilar and peribronchial infiltration 169 (60.6) 103 (64.4) 0.430
 Consolidation 33 (11.8) 19 (11.9) 0.988
Diagnosis
 Pneumonia 157 (56.3) 85 (53.1) 0.609
 Bronchiolitis 77 (27.6) 49 (30.6) 0.500
 Bronchitis 22 (7.9) 12 (7.5) 0.884
 Croup 17 (6.1) 9 (5.6) 0.841
 Asthma exacerbation 2 (0.7) 2 (1.3) 0.572
 Nasopharyngitis 4 (1.4) 3 (1.9) 0.722
Common virus
 RSV 125 (44.8) 84 (52.5)
 RV 52 (18.6) 86 (53.8)
 MPV 29 (10.4) -
 AdV - 54 (33.8)
 RSV 125 (44.8) 84 (52.5) 0.153
RSV subtype
 Type A 113 (90.4) 76 (90.5) 0.177
 Type B 12 (9.6) 8 (9.5) 0.735
RSV load
 1+ 5 (12.0) 10 (11.9) 0.983
 2+ 15 (12.0) 16 (19.0) 0.160
 3+ 95 (76.0) 52 (61.9) 0.029

Values are presented as number, mean±standard deviation, or number of cases (%).

WBC, white blood cell; CRP, C-reactive protein; RSV, respiratory syncytial virus; RV, rhinovirus; AdV, adenovirus; MPV, metapneumovirus.

*1–12 months, respiratory rate≥55/min; 13–36 months, respiratory rate≥30/min; 37–72 months, respiratory rate≥25/min; ≥73 months, respiratory rate≥22/min.

Table 4

Comparison of severity between single and coinfection

aard-4-360-i004
Variable Single infection (n = 279) Coinfection (n = 160) P-value
Fever ( ≥ 39℃) 54 (19.4) 42 (26.3) 0.453
Duration of fever ≥ 5 days 126 (45.2) 84 (52.5) 0.138
LOS ≥ 5 days 134 (30.5) 73 (16.6) 0.627
O2 therapy 21 (7.5) 6 (3.8) 0.113

Values are presented as number of cases (%)

LOS, length of stay.

Table 5

Prevalence of viral single and coinfection

aard-4-360-i005
Viral single and coinfection No. of cases (%)
No. of patients
 1 Viral infection 279 (63.6)
 2 Viral infection 126 (28.7)
 3 Viral infection 30 (6.8)
 4 Viral infection 4 (0.9)
No. of single infection
 RSV 125 (44.8)
 RV 52 (18.6)
 MPV 29 (10.4)
 PIV 23 (8.2)
 AdV 15 (5.4)
 BoV 14 (5.0)
 CoV 10 (3.6)
 IFV 6 (2.2)
 EV 5 (1.8)
Common 2 viral infection
 RSV+RV 28 (17.5)
 RSV+AdV 14 (8.8)
 RSV+CoV 12 (7.5)
 RV+MPV 8 (5.0)
 RSV+BoV 7 (4.4)
 RV+AdV 7 (4.4)
Common 3 viral infection
 RSV+RV+AdV 3 (1.9)
 RSV+RV+BoV 3 (1.9)
 RV+AdV+MPV 3 (1.9)
Common 4 viral infection
 RSV+RV+CoV+BoV 1 (0.6)
 RSV+RV+AdV+BoV 1 (0.6)
 RSV+RV+AdV+EV 1 (0.6)
 RSV+CoV+AdV+BoV 1 (0.6)

RSV, respiratory syncytial virus; RV, rhinovirus; MPV, metapneumovirus; PIV, parainfluenza; AdV, adenovirus; BoV, bocavirus; CoV, coronavirus; EV, enterovirus; IFV, influenza virus.

Table 6

Prevalence of single and coinfection for 4 viral subtypes

aard-4-360-i006
Virus Single infection (n = 279) Coinfection (n = 160)
RSV type A 113 (40.5) 76 (47.5)
RSV type B 12 (4.3) 8 (5.0)
PIV type 1 20 (7.2) 16 (10.1)
PIV type 2 0 (0) 0 (0)
PIV type 3 3 (1.1) 3 (1.9)
PIV type 4 0 (0) 6 (3.8)
CoV OC34 7 (2.5) 21 (13.2)
CoV NL63 2 (0.7) 6 (3.8)
CoV 229E 1 (0.4) 1 (0.6)
IFV type A 5 (1.8) 4 (2.5)
IFV type B 1 (0.4) 1 (0.6)

Values are presented as number of cases (%).

RSV, respiratory syncytial virus; PIV, parainfluenza; CoV, coronavirus; IFV, influenza virus.

References

1. Henrickson KJ. Viral pneumonia in children. Semin Pediatr Infect Dis. 1998; 9:217–233.
crossref
2. Renois F, Talmud D, Huguenin A, Moutte L, Strady C, Cousson J, et al. Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems. J Clin Microbiol. 2010; 48:3836–3842.
crossref
3. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol. 2003; 41:4160–4165.
crossref
4. Mengelle C, Mansuy JM, Pierre A, Claudet I, Grouteau E, Micheau P, et al. The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit. J Clin Virol. 2014; 61:411–417.
crossref
5. Imaz MS, Sequeira MD, Videla C, Veronessi I, Cociglio R, Zerbini E, et al. Clinical and epidemiologic characteristics of respiratory syncytial virus subgroups A and B infections in Santa Fe, Argentina. J Med Virol. 2000; 61:76–80.
crossref
6. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005; 191:1861–1868.
crossref
7. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005; 191:382–386.
crossref
8. Huang JJ, Huang TY, Huang MY, Chen BH, Lin KH, Jeng JE, et al. Simultaneous multiple viral infections in childhood acute lower respiratory tract infections in southern Taiwan. J Trop Pediatr. 1998; 44:308–311.
crossref
9. Saunders M, Gorelick MH. Evaluation of the sick child in the office and clinic. In : Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders;2011. p. 280.
10. Denny FW, Clyde WA Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr. 1986; 108(5 Pt 1):635–646.
crossref
11. Korean Academy of Asthma, Allergy and Clinical Immunology. Korean Academy of Pediatric Allergy and Respiratory Disease. National Strategic Coordination Center for Clinical Research. 2015 Korean guideline for asthma. Seoul: Korean Academy of Asthma;Allergy and Clinical Immunology;Korean Academy of Pediatric Allergy and Respiratory Disease;National Strategic Coordination Center for Clinical Research;Korean guideline for asthma;2015. p. 33–41.
12. ICD10Data.com. Acute nasopharyngitis [Internet]. c2015. cited 2016 Jan 1. Available from: http://www.icd10data.com/ICD10CM/Codes/J00-J99/J00-J06/J00-/J00.
13. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003; 143:5 Suppl. S118–S126.
crossref
14. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009; 360:588–598.
crossref
15. Wilkesmann A, Schildgen O, Eis-Hübinger AM, Geikowski T, Glatzel T, Lentze MJ, et al. Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr. 2006; 165:467–475.
crossref
16. Peng D, Zhao D, Liu J, Wang X, Yang K, Xicheng H, et al. Multipathogen infections in hospitalized children with acute respiratory infection. Virol J. 2009; 6:155.
17. Calvo C, García-García ML, Blanco C, Vázquez MC, Frías ME, Pérez-Breña P, et al. Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J Clin Virol. 2008; 42:268–272.
crossref
18. Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB. Dual respiratory virus infections. Clin Infect Dis. 1997; 25:1421–1429.
crossref
19. Foulongne V, Guyon G, Rodière M, Segondy M. Human metapneumovirus infection in young children hospitalized with respiratory tract disease. Pediatr Infect Dis J. 2006; 25:354–359.
crossref
20. Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A, Bagnaud A, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J. 2008; 27:213–217.
crossref
21. Marguet C, Lubrano M, Gueudin M, Le Roux P, Deschildre A, Forget C, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One. 2009; 4:e4596.
crossref
22. Greer RM, McErlean P, Arden KE, Faux CE, Nitsche A, Lambert SB, et al. Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? J Clin Virol. 2009; 45:10–15.
crossref
23. Eem YJ, Bae EY, Lee JH, Jeong DC. Risk Factors associated with respiratory virus detection in infants younger than 90 days of age. Korean J Pediatr Infect Dis. 2014; 21:22–28.
crossref
24. Kim HJ, Kim JH, Kang IJ. Association of respiratory viral infection and atopy with severity of acute bronchiolitis in infants. Pediatr Allergy Respir Dis. 2011; 21:302–312.
crossref
25. Choi EH, Lee HJ, Kim SJ, Eun BW, Kim NH, Lee JA, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis. 2006; 43:585–592.
crossref
26. Cebey-López M, Herberg J, Pardo-Seco J, Gómez-Carballa A, Martinón-Torres N, Salas A, et al. Viral co-Infections in pediatric patients hospitalized with lower tract acute respiratory infections. PLoS One. 2015; 10:e0136526.
crossref
27. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002; 165:1285–1289.
crossref
28. Jung HD, Cheong HM, Kim SS. Prevalence of respiratory viruses in patients with acute respiratory infections, 2014. Public Health Wkly Rep. 2014; 9:26–36.
29. Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004; 72:695–699.
crossref
30. Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol. 2010; 48:239–245.
crossref
31. El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011; 204:996–1002.
crossref
32. Brand HK, de Groot R, Galama JM, Brouwer ML, Teuwen K, Hermans PW, et al. Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis. Pediatr Pulmonol. 2012; 47:393–400.
crossref
33. Houben ML, Coenjaerts FE, Rossen JW, Belderbos ME, Hofland RW, Kimpen JL, et al. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol. 2010; 82:1266–1271.
crossref
34. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011; 49:2631–2636.
crossref
TOOLS
ORCID iDs

Yeon Hwa Ahn
https://orcid.org/http://orcid.org/0000-0003-3504-7346

Similar articles